Straumann Holding AG (SAUHF)
OTCMKTS · Delayed Price · Currency is USD
117.84
0.00 (0.00%)
At close: Dec 16, 2025
Straumann Holding AG Market Cap
Straumann Holding AG has a market cap or net worth of $19.07 billion as of December 17, 2025. Its market cap has decreased by -6.92% in one year.
Market Cap
19.07B
Enterprise Value
19.28B
Revenue
3.24B
Ranking
n/a
PE Ratio
38.45
Stock Price
$117.84
Market Cap Chart
Since June 2, 1998, Straumann Holding AG's market cap has increased from 219.03M to 19.07B, an increase of 8,606.26%. That is a compound annual growth rate of 17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 19.19B | -4.45% |
| Dec 30, 2024 | 20.08B | -21.74% |
| Dec 29, 2023 | 25.66B | 40.97% |
| Dec 30, 2022 | 18.20B | -45.99% |
| Dec 30, 2021 | 33.70B | 81.66% |
| Dec 30, 2020 | 18.55B | 19.37% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |